Vaxcyte
PCVX
PCVX
223 hedge funds and large institutions have $6.51B invested in Vaxcyte in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 202 → 223 (+21)
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
0.88% more ownership
Funds ownership: 108.03% → 108.91% (+0.88%)
Holders
223
Holding in Top 10
14
Calls
$9.9M
Puts
$2.94M
Top Buyers
| 1 | +$72.5M | |
| 2 | +$41.8M | |
| 3 | +$36.4M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$28.4M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$24.2M |
Top Sellers
| 1 | -$53.5M | |
| 2 | -$39M | |
| 3 | -$26.6M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$21.9M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$20.7M |